Richard E. Gregg
Plus aucun poste en cours
Profil
Richard E.
Gregg served as Vice President-Clinical Discovery at Bristol Myers Squibb Co. He was the Chief Scientific Officer at Vitae Pharmaceuticals LLC from 2008 to 2016.
Prior to that, he worked as a Principal at the National Heart, Lung & Blood Institute.
Gregg received his undergraduate and graduate degrees from Iowa State University and his doctorate from Stanford University School of Medicine.
Anciens postes connus de Richard E. Gregg
| Sociétés | Poste | Fin |
|---|---|---|
| VITAE PHARMACEUTICALS INC | Directeur Technique/Scientifique/R&D | 01/01/2016 |
| National Heart, Lung & Blood Institute | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Formation de Richard E. Gregg
| Iowa State University | Graduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Entreprise privées | 2 |
|---|---|
Vitae Pharmaceuticals LLC
 Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vitae Pharmaceuticals LLC is a clinical-stage bio-pharmaceutical company, which engages in discovering and developing novel, small molecule drugs for diseases, including chronic kidney disease, diabetes and Alzheimer's disease, and autoimmune disorders, acute coronary syndrome, and immuno-oncology. The company was founded by John J. Baldwin, Bartosz A. Grzybowski, George M. Whitesides, and Eugene Shakhnovich on May 21, 2001 and is headquartered in Fort Washington, PA. | Health Technology |
| National Heart, Lung & Blood Institute | Government |
